Early genetic events in the formation of astrocytomas

Current Opinion in Neurology

Volumn 13, Issue 6, 2000, Pages 613-617

  Henson, John W ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASTIC CARCINOMA; ASTROCYTOMA; CANCER GROWTH; GENETIC ANALYSIS; GLIOBLASTOMA; HUMAN; REVIEW;

ASTROCYTOMA; BRAIN NEOPLASMS; HUMANS;

EID: 0034533238     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200012000-00001     Document Type: Review

References (34)

1. Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter
2. A tiger behind many doors: Multiple genetic pathways to malignant glioma
3. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas
4. Genetic alterations associated with the evolution and progression of astrocytic brain tumors
5. Histopathology, classification, and grading of gliomas
6. Suspected low-grade glioma: Is deferring treatment safe?
7. Low-grade gliomas
8. Alteration of cell cycle regulatory genes in primary (de novo) and secondary glioblastomas
9. Clonal genomic alterations in glioma malignancy stages
10. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: Results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials
11. Long-term survival in patients with malignant astrocytoma
12. Ten-year survival among patients with supratentorial astrocytomas grade III and IV
13. Age-dependent rate of anaplastic transformation in low-grade astrocytoma
14. Comparative genomic hybridization as a tool in tumour cytogenetics
15. Investigation of genetic alterations associated with the grade of astrocytic tumor by comparative genomic hybridization
16. Accumulation of genetic changes is associated with poor prognosis in grade II astrocytomas
17. Recurrent gain of chromosome arm 7q in low-grade astrocytic tumors studied by comparative genomic hybridization
18. Characterization of genomic alterations associated with glioma progression by comparative genomic hybdrization
19. Comprehensive allelotype and genetic analysis of 466 human nervous system tumors
20. Platelet-derived growth factor and its receptors in human glioma tissue: Expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops
21. Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop
22. The p53 gene and protein in human brain tumors
23. Comparative study of p53 gene and protein alterations in human astrocytic tumors
24. Prognostic implications of p53 overexpression in supratentorial astrocytic tumors
25. Molecular analysis of microdissected de novo glioblastomas and paired astrocytic tumors
26. p53 mutation, expression, and DNA ploidy in evolving gliomas: Evidence for two pathways of progression
27. TP53 alterations and clinical outcome in low grade as trocytomas
28. Prognostic significance of p53 immunoreactivity in patients with gliomas
29. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies
30. Somatic mutations in the brain: Relationship to aging?
31. Refining the telomere-telomerase hypothesis of aging and cancer
32. Somatic mutations in the brain: Relastionship to aging?
33. Refining the telomere-telomerase hypothesis of aging and cancer